Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.
Abstract
The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders. Small intermediates - soluble oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insoluble deposits might function as reservoirs of the bioactive oligomers. These emerging concepts are exemplified by Alzheimer's disease, in which amyloid beta-protein oligomers adversely affect synaptic structure and plasticity. Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This observation suggests that oligodendrocytes could potentially generate a relatively higher proportion of longer Aβ species, which are more prone to aggregation [28]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“The increased Aβ 42:40 ratio in oligodendrocytes could contribute to the high proportion of soluble aggregates [28,42,43]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“and, consequently, could be more pathogenic than shorter Aβ species”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [8]
In the citing paper
“Dysregulation of A peptide metabolism is hypothesized to initiate pathogenic cascades that lead to Alzheimer's disease (AD) (Haass and Selkoe, 2007).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Haass and Selkoe, 2007
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Self-citationSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“These and other findings led to the formal proposal of a hypothesis of disease in which excessive Aβ accumulation and deposition could trigger a complex downstream cascade that resulted in the symptoms of A”
ResultRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“In a similar manner, breakthrough discoveries of causative genes allowed the subsequent identification of aggregation-prone proteins in disorders such as amyotrophic lateral sclerosis (ALS”
ResultUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“More recently, TDP43 was found to be deposited in tau- and synuclein-negative inclusions in a disorder designated as frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) as well as in AL”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Shortly thereafter, a distinct APP missense mutation was found in a family with early-onset A”
Background
Cited by
Items 701–800 of 1,119
Wallin, C., Sholts, S. B., Österlund, N., Luo, J., Jarvet, J., Roos, P. M., Ilag, L. L., Gräslund, A., & Wärmländer, S. K. T. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-13759-5 · Cited by 131
Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease
Madav, Y., Wairkar, S., & Prabhakar, B. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.004 · Cited by 111
Kulenkampff, K., Perez, A.-M. W., Sormanni, P., Habchi, J., & Vendruscolo, M. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00254-9 · Cited by 116
Aβ-globulomers are formed independently of the fibril pathway
Gellermann, G. P., Byrnes, H., Striebinger, A., Ullrich, K., Mueller, R., Hillen, H., & Barghorn, S. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.010 · Cited by 112
“Advances in the understanding of AD pathogenesis provide strong support for a modified version of the βamyloid cascade hypothesis (Haass and Selkoe 2007).”
BackgroundRocha, S., Thünemann, A. F., Pereira, M. D. C., Coelho, M. A. N., Möhwald, H., & Brezesinski, G. (2008) · Biophysical Chemistry · doi:10.1016/j.bpc.2008.06.010 · Cited by 124
“Prefibrillar aggregates are toxic to cells [6, 7].”
An Integrated View on Vascular Dysfunction in Alzheimer’s Disease
Klohs, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505625 · Cited by 111
Carulla, N., Zhou, M., Arimon, M., Gairí, M., Giralt, E., Robinson, C. V., & Dobson, C. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812227106 · Cited by 112
“Although early hypotheses proposed amyloid fibrils as the primary pathogenic agent, much recent evidence supports the view that smaller aggregates populated during the fibril assembly process represent the primary culprits (4, 5).”
BackgroundProtein misfolding and amyloid nucleation through liquid–liquid phase separation
Mukherjee, S., Poudyal, M., Dave, K., Kadu, P., & Maji, S. K. (2024) · Chemical Society Reviews · doi:10.1039/d3cs01065a · Cited by 123
Koch, P., Tamboli, I. Y., Mertens, J., Wunderlich, P., Ladewig, J., Stüber, K., Esselmann, H., Wiltfang, J., Brüstle, O., & Walter, J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.02.012 · Cited by 129
Silverberg, G. D., Miller, M. C., Messier, A. A., Majmudar, S., Machan, J. T., Donahue, J. E., Stopa, E. G., & Johanson, C. E. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c8ad2f · Cited by 111
“It is recognized that AD is a multifactorial disease, with aging playing a major role, and that AA accumulation seems to be an integral part of the disease (6); however, its accumulation in AD does not correlate well with the onset and progression of clinical impairment (50, 51).”
BackgroundAmyloid-β-Induced Dysregulation of AMPA Receptor Trafficking
Guntupalli, S., Widagdo, J., & Anggono, V. (2016) · Neural Plasticity · doi:10.1155/2016/3204519 · Cited by 110
“These deleterious effects could contribute to the cognitive deficit and memory loss associated with AD, indicating that “synaptic failure” is likely to be one of the earliest events that occurs in the pathogenesis of AD prior to neuronal loss [6–8].”
BackgroundSaito, S., Yamamoto, Y., Maki, T., Hattori, Y., Ito, H., Mizuno, K., Harada-Shiba, M., Kalaria, R. N., Fukushima, M., Takahashi, R., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0429-5 · Cited by 110
Costa, R. O., Lacor, P. N., Ferreira, I. L., Resende, R., Auberson, Y. P., Klein, W. L., Oliveira, C. R., Rego, A. C., & Pereira, C. M. F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00848.x · Cited by 110
“However, it is now well accepted that other Ab species, specifically AbO, are the main neurotoxic species involved in AD (Klein, 2006; Haass & Selkoe, 2007; Sakono & Zako, 2010).”
BackgroundMetal Binding Dictates Conformation and Function of the Amyloid Precursor Protein (APP) E2 Domain
Dahms, S. O., Könnig, I., Roeser, D., Gührs, K.-H., Mayer, M. C., Kaden, D., Multhaup, G., & Than, M. E. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.057 · Cited by 110
Mayes, J., Tinker, C. L., Kolosov, O. V., Zhang, H., Tabner, B. J., & Allsop, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525212 · Cited by 124
Liang, B., Duan, B.-Y., Zhou, X.-P., Gong, J.-X., & Luo, Z.-G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117960 · Cited by 110
Kell, D. B., & Pretorius, E. (2018) · Biological Reviews · doi:10.1111/brv.12407 · Cited by 110
“…cytotoxic (Aitken et al., 2010; Baglioni et al., 2006; Bucciantini et al., 2002; Dobson, 2013; Fändrich, 2012; Glabe, 2006; Göransson et al., 2012; Haass & Selkoe, 2007; Janson et al., 1999; Kayed et al., 2003; Ke et al., 2017; Konarkowska et al., 2006; Meier et al., 2006; Pillay & Govender,…”
Interactions between amyloid β peptide and lipid membranes
Niu, Z., Zhang, Z., Zhao, W., & Yang, J. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.04.004 · Cited by 109
Cenini, G., Rüb, C., Bruderek, M., & Voos, W. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-05-0313 · Cited by 110
An, J., Kim, K., Lim, H. J., Kim, H. Y., Shin, J. W., Park, I., Cho, I., Kim, H. Y., Kim, S., McLean, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44818-x · Cited by 125
“Instead,small aggregates-comprising aqueous soluble A β oligomers during the dynamicaggregation cascade are pathophysiologicallyresponsible for the synaptotoxicity, in fl ammation, tau hyperphosphorylation, non-fi brotictangling,andneuronaldeathinthebrain,resultingincognitive impairment 7 – 9 .”
BackgroundActivation of TRPML1 Clears Intraneuronal Aβ in Preclinical Models of HIV Infection
Bae, M., Patel, N., Xu, H., Lee, M., Tominaga-Yamanaka, K., Nath, A., Geiger, J., Gorospe, M., Mattson, M. P., & Haughey, N. J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0210-14.2014 · Cited by 110
“Although soluble and intraneuronal A are commonly found in AD, senile plaques are the defining neuropathological observation (Haass and Selkoe, 2007).”
BackgroundEllagic acid promotes Aβ42 fibrillization and inhibits Aβ42-induced neurotoxicity
Feng, Y. N., Yang, S., Du, X., Zhang, X., Sun, X., Zhao, M., Sun, G., & Liu, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.130 · Cited by 123
Tethered and Polymer Supported Bilayer Lipid Membranes: Structure and Function
Andersson, J., & Köper, I. (2016) · Membranes · doi:10.3390/membranes6020030 · Cited by 130
“Amyloid β-oligomers and other misfolded oligomers and proteins are known to be a significant factor in the development of Parkinson’s [54] and Alzheimer’s disease [55]. tBLMs have been used to investigate the effect of these peptides on the cellular membrane, showing that oligomer accumulation at the membrane interfac…”
BackgroundResveratrol ameliorates spatial learning memory impairment induced by Aβ 1–42 in rats
Wang, R., Zhang, Y., Li, J., & Zhang, C. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.051 · Cited by 117
“Aβ deposition is thought to play a pivotal role in a cascade of harmful events, including inflammatory responses, oxidative stress, synaptotoxins, neuronal injury and death (Klein et al., 2004; Lesne et al., 2006; Nunomura et al., 2006; Haass and Selkoe, 2007; Walsh and Selkoe, 2007).”
Rossi, A., Rigotto, G., Valente, G., Giorgio, V., Basso, E., Filadi, R., & Pizzo, P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.060 · Cited by 109
“In particular, mutant forms of presenilin 2 (PS2), linked to familial cases of AD (FAD) (Haass and Selkoe, 2007), dampen mitochondrial Ca rises upon cell stimulations (Filadi et al.”
BackgroundTransgenic Drosophila models of Alzheimer’s disease and tauopathies
Iijima‐Ando, K., & Iijima, K. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0234-4 · Cited by 128
“However, recent experimental data indicates that the soluble prefibrillar assemblies cause more severe synaptic dysfunctions, cognitive defects, and neurodegeneration than do the mature fibrils (Haass and Selkoe 2007).”
Cao, Q., Wang, W., Williams, J. B., Yang, F., Wang, Z.-J., & Yan, Z. (2020) · Science Advances · doi:10.1126/sciadv.abc8096 · Cited by 108
Targeting disordered proteins with small molecules using entropy
Heller, G. T., Sormanni, P., & Vendruscolo, M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.07.004 · Cited by 107
Fischer, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.038 · Cited by 122
“About 2e5% of all AD patients suffer from familial AD that is characterized by an early onset (early onset AD, eoAD) and is explained by mutations in genes that regulated processes of the amyloid precursor protein (Haass and Selkoe, 2007).”
BackgroundKyrtsos, C. R., & Baras, J. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139574 · Cited by 108
Vascular Risk and β‐Amyloid Are Synergistically Associated with Cortical Tau
Rabin, J. S., Yang, H., Schultz, A. P., Hanseeuw, B. J., Hedden, T., Viswanathan, A., Gatchel, J. R., Marshall, G. A., Kilpatrick, E., Klein, H., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25399 · Cited by 108
Gadad, B. S., Britton, G. B., & Rao, K. S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110182 · Cited by 108
“In the case of A , the insoluble amyloid plaque density correlates weakly with the severity of AD; the extent of the dementia is more robustly gauged by the concentration of soluble A species [35].”
Identification of Physiological and Toxic Conformations in Aβ42 Aggregates
Masuda, Y., Uemura, S., Ohashi, R., Nakanishi, A., Takegoshi, K., Shimizu, T., Shirasawa, T., & Irie, K. (2009) · ChemBioChem · doi:10.1002/cbic.200800411 · Cited by 108
Zhang, F., Kang, Z., Li, W., Xiao, Z., & Zhou, X. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.12.022 · Cited by 113
Richman, M., Wilk, S., Chemerovski‐Glikman, M., Wärmländer, S. K. T. S., Wahlström, A., Gräslund, A., & Rahimipour, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja310064v · Cited by 108
Protein aggregation as a paradigm of aging
Lindner, A. B., & Démarez, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.005 · Cited by 127
Bao, F., Wicklund, L., Lacor, P. N., Klein, W. L., Nordberg, A. K., & Marutle, A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.003 · Cited by 126
“It has earlier been hypothesized that large, insoluble deposits of A may serve as reservoirs of bioactive synaptotoxic A oligomers (Haass and Selkoe, 2007).”
BackgroundElAli, A., & Rivest, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00045 · Cited by 108
“…cleavage of the Amyloid Precursor Protein (APP) produces beta-amyloid (Aβ) peptides, namely Aβ1−40 and Aβ1−42 (Hardy and Selkoe, 2002), which oligomerize to form small oligomers of 2–12 peptides (i.e., Aβ oligomers), and aggregate leading to Aβ plaques generation (Haass and Selkoe, 2007).”
BackgroundInfluentialMolecules that Target beta‐Amyloid
Stains, C. I., Mondal, K., & Ghosh, I. (2007) · ChemMedChem · doi:10.1002/cmdc.200700140 · Cited by 125
Faller, P., & Hureau, C. (2012) · Chemistry – A European Journal · doi:10.1002/chem.201202697 · Cited by 108
Protein Solubility and Protein Homeostasis: A Generic View of Protein Misfolding Disorders
Vendruscolo, M., Knowles, T. P. J., & Dobson, C. M. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a010454 · Cited by 108
Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity
Smith, L. M., & Strittmatter, S. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024075 · Cited by 109
Epigenetic memory: The Lamarckian brain
Fischer, A. (2014) · The EMBO Journal · doi:10.1002/embj.201387637 · Cited by 107
“AD is a debilitating disease that arises on the pathological background of amyloid-beta plaques, neurofibrillary tangles and severe neuronal loss, eventually leading to dementia (Haass & Selkoe, 2007).”
Zhao, L., Gottesdiener, A. J., Parmar, M., Li, M., Kaminsky, S. M., Chiuchiolo, M. J., Sondhi, D., Sullivan, P. M., Holtzman, D. M., Crystal, R. G., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.020 · Cited by 107
“Since oligomeric Ab has been reported to be neurotoxic and responsible for cognitive impairment in APP transgenic mice (Haass and Selkoe, 2007), we also assessed whether treatment with AAVrh.10-APOE2 altered the levels of oligomeric Ab.”
The role of amyloid β in the pathogenesis of Alzheimer's disease
Gilbert, B. J. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201515 · Cited by 107
Nakamura, T., & Lipton, S. A. (2010) · Apoptosis · doi:10.1007/s10495-010-0476-x · Cited by 107
“Recently, several lines of evidence have suggested that soluble oligomers of Ab represent the most toxic form of the peptide [ 14 ].”
BackgroundAβ40 and Aβ42 Amyloid Fibrils Exhibit Distinct Molecular Recycling Properties
Sánchez, L., Madurga, S., Pukala, T., Vilaseca, M., López-Iglesias, C., Robinson, C. V., Giralt, E., & Carulla, N. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1117123 · Cited by 105
The epigenetic bottleneck of neurodegenerative and psychiatric diseases
Sananbenesi, F., & Fischer, A. (2009) · bchm · doi:10.1515/bc.2009.131 · Cited by 106
“In AD patients, a shift towards the production of more toxic Ab-peptides, such as Ab42, is commonly observed (Haass and Selkoe, 2007).”
BackgroundConvertino, M., Pellarin, R., Catto, M., Carotti, A., & Caflisch, A. (2009) · Protein Science · doi:10.1002/pro.87 · Cited by 106
“hydrogen bonds, which has three main consequences: (1) the disruption of the local intermolecular hydrogen bond geometry, ( 2 ) destabilization of the b-sheet structure, and (3) global disorganization of the oligomer, that is, reduction of the total order.”
BackgroundProtein Phosphatases and Alzheimer's Disease
Braithwaite, S. P., Stock, J. B., Lombroso, P. J., & Nairn, A. C. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396456-4.00012-2 · Cited by 107
“At a cellular level, AD is characterized by marked neuronal and neuritic loss.2 The major pathological hallmarks of AD are the aberrant accumulation of the amyloid-b peptide (Ab) in the form of amyloid plaques and the intracellular formation of hyperphosphorylated tau protein inclusions (neurofibrillary tangles, or NF…”
InfluentialMast, N., Saadane, A., Valencia-Olvera, A., Constans, J., Maxfield, E., Arakawa, H., Li, Y., Landreth, G., & Pikuleva, I. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.026 · Cited by 107
“Insoluble amyloid-β1-42 peptide is predominant in the 5XFAD mice and the initial amyloid species that deposit into amyloid plaques in all forms of Alzheimer’s disease (Haass and Selkoe, 2007).”
BackgroundThe Role of Mitochondrial Calcium Homeostasis in Alzheimer’s and Related Diseases
Ryan, K. C., Ashkavand, Z., & Norman, K. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239153 · Cited by 114
“Abeta plaques on their own have been shown to interfere with synaptic function and cause extensive neuronal death, especially within the cortical and hippocampal regions of the brain that are responsible for learning and memory [3].”
BackgroundFišar, Z. (2022) · Biomolecules · doi:10.3390/biom12111676 · Cited by 120
Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
Iwata, N., Sekiguchi, M., Hattori, Y., Takahashi, A., Asai, M., Ji, B., Higuchi, M., Staufenbiel, M., Muramatsu, S.-I., & Saido, T. C. (2013) · Scientific Reports · doi:10.1038/srep01472 · Cited by 107
Liu, L., Orozco, I. J., Planel, E., Wen, Y., Bretteville, A., Krishnamurthy, P., Wang, L., Herman, M., Figueroa, H. Y., Yu, W. H., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.005 · Cited by 120
Côté, S., Laghaei, R., Derreumaux, P., & Mousseau, N. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp2126366 · Cited by 111
Noguchi‐Shinohara, M., Ono, K., Hamaguchi, T., Iwasa, K., Nagai, T., Kobayashi, S., Nakamura, H., & Yamada, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126422 · Cited by 120
Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons
Nieweg, K., Andreyeva, A., van Stegen, B., Tanriöver, G., & Gottmann, K. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.72 · Cited by 106
Kumar, S., Wirths, O., Stüber, K., Wunderlich, P., Koch, P., Theil, S., Rezaei-Ghaleh, N., Zweckstetter, M., Bayer, T. A., Brüstle, O., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1546-0 · Cited by 105
“1 3 may be inert or even protective [1, 4, 15, 19, 47].”
Cinnamon, a promising prospect towards Alzheimer’s disease
Momtaz, S., Hassani, S., Khan, F., Ziaee, M., & Abdollahi, M. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.011 · Cited by 122
Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
Baig, M. H., Ahmad, K., Rabbani, G., & Choi, I. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00021 · Cited by 104
“…| Article 21 It has been reported oligomers of diffusible Aβ, such as, protofibrils, prefibrillar aggregates and Aβ-derived diffusible ligands (ADDLs), are the main toxic players during the development and progression of AD (Haass and Selkoe, 2007; Shankar et al., 2008; Funke and Willbold, 2012).”
BackgroundPenke, B., Bogár, F., Crul, T., Sántha, M., Tóth, M. E., & Vígh, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010325 · Cited by 121
“The formation of extracellular aggregates is mainly a tool for sequestration of toxic, pathogenic proteins since, in case of Aβ, the soluble oligomers and protofibrils are the most cytotoxic forms [129,130].”
BackgroundFyn-Tau-Amyloid: A Toxic Triad
Haass, C., & Mandelkow�, E. (2010) · Cell · doi:10.1016/j.cell.2010.07.032 · Cited by 117
Self-citationHead, E., Pop, V., Vasilevko, V., Hill, M., Saing, T., Sarsoza, F., Nistor, M., Christie, L.-A., Milton, S., Glabe, C., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0208-08.2008 · Cited by 106
“Oligomers are thought to be one type of assembly state of A that might be particularly toxic to neurons and synapses and linked to cognitive dysfunction (Walsh et al., 2002; Lesne et al., 2006; Haass and Selkoe, 2007).”
BackgroundAβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease
Gao, C. M., Yam, A. Y., Wang, X., Magdangal, E., Salisbury, C., Peretz, D., Zuckermann, R. N., Connolly, M. D., Hansson, O., Minthon, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015725 · Cited by 105
“Its chemical composition is also poorly defined, although several lines of evidence suggest that AD-associated oligomers are primarily composed of Ab42 [3].”
BackgroundMitochondria-Targeted Antioxidants as Promising Drugs for Treatment of Age-Related Brain Diseases
Skulachev, V. P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111391 · Cited by 105
“memory accompanying AD [17–19].”
Wang, J., Ohno‐Matsui, K., Yoshida, T., Shimada, N., Ichinose, S., Sato, T., Mochizuki, M., & Morita, I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21742 · Cited by 105
“Interestingly, Ab is the main component of the senile plaques found in the brain of patients with Alzheimer’s disease (AD) (Vassar et al., 1999; Takasugi et al., 2003; Haass and Selkoe, 2007).”
BackgroundAndreu, C. I., Woehlbier, U., Torres, M., & Hetz, C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.023 · Cited by 105
“Specific mutations in an underlying gene (familial cases) or structural changes of a normal protein (sporadic cases) are the cause of the accumulation of misfolded proteins in PMDs, which are present in the form of small oligomers, aggregates or large inclusions or extracellular deposits [5].”
BackgroundNGF steers microglia toward a neuroprotective phenotype
Rizzi, C., Tiberi, A., Giustizieri, M., Marrone, M. C., Gobbo, F., Carucci, N. M., Meli, G., Arisi, I., D'Onofrio, M., Marinelli, S., et al. (2018) · Glia · doi:10.1002/glia.23312 · Cited by 105
Effects of rosmarinic acid on nervous system disorders: an updated review
Rahbardar, M. G., & Hosseinzadeh, H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01935-w · Cited by 115
“Alzheimer’s disease (AD) has been marked out by the cumulative expansion of intraneuronal filaments as a result of the microtubule-associated protein Tau and the extracellular vascular and parenchymal amyloid residues mainly containing the protein Aβ (Haass and Selkoe 2007).”
BackgroundProtein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response
Ajmal, M. R. (2023) · Diseases · doi:10.3390/diseases11010030 · Cited by 131
“Later these oligomers can form amyloid fibrils [103].”
BackgroundKlementieva, O. L., Benseny‐Cases, N., Gella, A., Appelhans, D., Voit, B. I., & Cladera, J. (2011) · Biomacromolecules · doi:10.1021/bm2008636 · Cited by 105
The effects of cholesterol on learning and memory
Schreurs, B. G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.010 · Cited by 105
“The initial debate about the relative effects of soluble versus insoluble beta amyloid (Despande et al., 2006; Gouras et al., 2005; Haass and Selkoe, 2007; Kayed et al., 2003; Zerbinatti et al., 2004) has given way to a more recent discussion of the oligomeric form of beta amyloid with Neurosci…”
BackgroundMa, T., Du, X., Pick, J. E., Sui, G., Brownlee, M., & Klann, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2107-12.2012 · Cited by 104
“The amyloid (A ) hypothesis, one of the leading theories for AD etiology, has resulted in current research focusing on lowering levels of brain A , a small peptide derived from amyloid precursor protein (APP) (Haass and Selkoe, 2007).”
BackgroundRole of transient receptor potential ankyrin 1 channels in Alzheimer’s disease
Lee, K.-I., Lee, H., Lin, H., Tsay, H.-J., Tsai, F.-C., Shyue, S., & Lee, T. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0557-z · Cited by 116
“triggers inflammation and neuron dysfunction [3, 5, 60].”
BackgroundInfluentialThe Exceptional Vulnerability of Humans to Alzheimer’s Disease
Walker, L. C., & Jucker, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.001 · Cited by 104
Bosson, A., Paumier, A., Boisseau, S., Jacquier-Sarlin, M., Buisson, A., & Albrieux, M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0194-8 · Cited by 103
“Yet, small soluble Aβ oligomers are sufficient to induce several features of the AD phenotype [1].”
BackgroundKaji, S., Berghoff, S. A., Spieth, L., Schlaphoff, L., Sasmita, A. O., Vitale, S., Büschgens, L., Kedia, S., Zirngibl, M., Nazarenko, T., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.014 · Cited by 104
Self-citationMechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane
Beyer, K. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0014-9 · Cited by 122
“A recent review article comprehensively deals with Ab aggregation [146].”
BackgroundNOX Activity Is Increased in Mild Cognitive Impairment
Bruce-Keller, A. J., Gupta, S., Parrino, T. E., Knight, A. G., Ebenezer, P. J., Weidner, A. M., LeVine, H., Keller, J. N., & Markesbery, W. R. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2823 · Cited by 104
“Evidence suggests that smaller oligomeric A b species correlate well with behavioral deficits and further are potent mediators of synaptotoxicity and neuronal death and [reviewed in (14, 44)].”
Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment
Garg, S., Timm, T., Mandelkow, E.-M., Mandelkow, E., & Wang, Y. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.008 · Cited by 103
“Alzheimer’s disease is characterized by 2 main pathologic types of protein aggregation, intracellular neurofibrillary tangles (NFTs) made up of Tau protein and extracellular senile plaques (SPs) formed by -amyloid (A ) (Ballatore et al., 2007; Haass and Selkoe, 2007).”
BackgroundGuerrero‐Munoz, M. J., Castillo‐Carranza, D. L., & Kayed, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.023 · Cited by 111
RAN translation—What makes it run?
Green, K. M., Linsalata, A. E., & Todd, P. K. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.003 · Cited by 115
“Alternatively, it may be that DRP inclusion formation is neuroprotective while the soluble DRPs oligomers drive toxicity, as has been proposed in several other neurodegenerative proteinopathies (Saudou et al., 1998; Haass and Selkoe, 2007).”
Physical determinants of the self-replication of protein fibrils
Šarić, A., Buell, A. K., Meisl, G., Michaels, T. C. T., Dobson, C. M., Linse, S. S., Knowles, T. P. J., & Frenkel, D. (2016) · Nature Physics · doi:10.1038/nphys3828 · Cited by 105
Tsukada, K., Shinki, S., Kaneko, A., Murakami, K., Irie, K., Murai, M., Miyoshi, H., Dan, S., Kawaji, K., Hayashi, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15664-4 · Cited by 107
Mitra, S., Anjum, J., Muni, M., Das, R. C., Rauf, A., Islam, F., Emran, T. B., Semwal, P., Hemeg, H. A., Alhumaydhi, F. A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112877 · Cited by 107
Selective induction of calcineurin activity and signaling by oligomeric amyloid beta
Reese, L. C., Zhang, W., Dineley, K. T., Kayed, R., & Taglialatela, G. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00434.x · Cited by 103
Thal, D. R., Papassotiropoulos, A., Saido, T. C., Griffin, W. S. T., Mrak, R. E., Kölsch, H., Tredici, K. D., Attems, J., & Ghebremedhin, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0707-9 · Cited by 103
“Increasing evidence points to the hypothesis that amyloid b-protein (Ab) aggregates are of major importance for the development of Alzheimer’s disease (AD) [30, 41, 85].”
BackgroundmiR‐186 is decreased in aged brain and suppresses BACE 1 expression
Kim, J., Yoon, H., Chung, D., Brown, J. L., Belmonte, K. C., & Kim, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13507 · Cited by 111
NLRP3 Inflammasome: Activation and Regulation in Age‐Related Macular Degeneration
Gao, J., Liu, R. T., Cao, S., Cui, J. Z., Wang, A., To, E., & Matsubara, J. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/690243 · Cited by 101
“It is further proposed that the spontaneous release of drusen components during drusen regression in AMD development may result in RPE loss in GA [16].”
BackgroundIs the Amyloid Hypothesis of Alzheimer's disease therapeutically relevant?
Teich, A. F., & Arancio, O. (2012) · Biochemical Journal · doi:10.1042/bj20120653 · Cited by 102
Li, Y., Yang, J., Liu, H., Yang, J., Du, L., Feng, H., Tian, Y., Cao, J., & Ran, C. (2017) · Chemical Science · doi:10.1039/c7sc02050c · Cited by 106
Comparing the Aggregation Free Energy Landscapes of Amyloid Beta(1–42) and Amyloid Beta(1–40)
Zheng, W., Tsai, M.-Y., & Wolynes, P. G. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08089 · Cited by 102
Highly Disordered Amyloid-β Monomer Probed by Single-Molecule FRET and MD Simulation
Meng, F., Bellaiche, M. M. J., Kim, J. Y., Zerze, G. H., Best, R. B., & Chung, H. S. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2017.12.025 · Cited by 108
Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives
Ide, K., Matsuoka, N., Yamada, H., Furushima, D., & Kawakami, K. (2018) · Molecules · doi:10.3390/molecules23092357 · Cited by 102
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Shao, B.-Z., Cao, Q., & Liu, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00320 · Cited by 102
“Neurodegenerative diseases refer to a group of disorders with progressive loss of structure or function of neurons and finally lead to neuronal death (Haass and Selkoe, 2007).”
BackgroundThe cellular model for Alzheimer's disease research: PC12 cells
Xie, D., Deng, T., Zhai, Z., Sun, T., & Xu, Y. D. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1016559 · Cited by 118
Biophysical Studies of the Amyloid β‐Peptide: Interactions with Metal Ions and Small Molecules
Wärmländer, S. K. T. S., Tiiman, A., Abelein, A., Luo, J., Jarvet, J., Söderberg, K. L., Danielsson, J., & Gräslund, A. (2013) · ChemBioChem · doi:10.1002/cbic.201300262 · Cited by 110
Winkler, E., Kamp, F., Scheuring, J., Ebke, A., Fukumori, A., & Steiner, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356659 · Cited by 101
“A 42, and as demonstrated recently A 43 as well (2), is highly pathogenic and believed to cause AD by triggering a pathogenic series of events, the so-called amyloid cascade that ultimately leads to neurodegeneration and dementia (1, 3).”
Backgroundα-Synuclein Oligomers: an Amyloid Pore?
Stöckl, M. T., Zijlstra, N., & Subramaniam, V. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8331-4 · Cited by 105
Metadata
- Authors
- Haass, C., & Selkoe, D. J.
- Affiliations
- Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2007-02
- Volume
- 8
- Issue
- 2
- Pages
- 101-112
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1980825524
- Cited by
- 4,744
- References
- 135
- Citations by year
- 2026: 135 · 2025: 171 · 2024: 165 · 2023: 170 · 2022: 195 · 2021: 239 · 2020: 273 · 2019: 247 · 2018: 276 · 2017: 290 · 2016: 331 · 2015: 313 · 2014: 285 · 2013: 307 · 2012: 327
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, neurodegeneration, protein misfolding, protein aggregation, synaptic dysfunction, synaptic plasticity, Parkinson's disease, Huntington's disease, prion disease, neuronal dysfunction
- MeSH terms
- Alzheimer Disease, Cell Membrane, Humans, Memory Disorders, Models, Biological, Nerve Degeneration, Solubility, Synapses, Signal Transduction, Amyloid beta-Peptides, Protein Folding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.